Learn how personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to ...
Xenon nears a Q3 2026 NDA with strong Phase 3 epilepsy data and a cash runway to 2029. Click here to read an analysis of XENE ...
Ketogenic diets, originally developed in the 1920s to treat epilepsy, have been adapted in the past few decades as a strategy ...
A patient diagnosed with glioblastoma, an aggressive form of terminal brain cancer, is marking seven years since his ...
In 2024, the Hughes Report called for a two-stage redress scheme for patients affected by vaginal mesh and sodium valproate. It was hoped these would come into effect late last year, but no ...
Researchers said the keto diet was found to suppress tumors in one part of the body but accelerated growth in another.
Epilepsy affects over 50 million people worldwide, making it one of the most common neurological disorders. Although ...
New research from Texas A&M University could change the way traumatic brain injuries and seizures are treated.
A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment ...
SCN2A-related developmental epileptic encephalopathy (DEE) is a rare, severe form of childhood epilepsy and one of the most ...
Aside from standard healthcare, functional medicine aims to improve brain health in the hopes of helping epilepsy patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results